Narkewar kwararar jini cikin sauri ya dogara ne akan maganin magani. A wasu lokuta, ana kuma amfani da tiyatar cirewar jini.

Ga cikakken bayani game da wannan:

1 Maganin thrombolysis na magani

1.1 Magungunan da aka saba amfani da su

Urokinase: wani enzyme na halitta da aka samo daga fitsarin ɗan adam ko kuma ƙwayoyin koda suka haɗa. Yana iya aiki kai tsaye akan tsarin fibrinolytic na ciki, kunna plasminogen zuwa plasmin, kuma ta haka yana narkar da ɗigon jini.

Streptokinase: wani furotin da aka samo daga ruwan hemolytic streptococci. Yana iya ɗaurewa da plasminogen don samar da wani hadadden abu, yana haɓaka canza plasminogen zuwa plasmin, sannan kuma yana narkar da gudan jini.

Mai kunna plasminogen nama mai sake haɗawa (rt-PA): wani glycoprotein ne wanda zai iya kunna plasminogen kuma yana da babban sha'awa ga fibrin. Yana iya yin aiki a kan fibrin a cikin ɗigon jini don lalata shi da kuma cimma manufar narkar da ɗigon jini. Idan aka kwatanta da urokinase da streptokinase, rt-PA yana da ingantaccen aikin thrombolytic kuma yana da ƙarancin rikitarwa na zubar jini.

1.2 Lokacin magani

Ga cututtuka kamar su bugun zuciya mai tsanani da bugun zuciya, lokacin da za a yi amfani da maganin thrombolytic yana da matuƙar muhimmanci. Gabaɗaya, ya kamata a yi wa marasa lafiya da ke fama da bugun zuciya mai tsanani magani cikin awanni 12 bayan fara shi, zai fi kyau a yi masa magani cikin awanni 3-6; marasa lafiya da ke fama da bugun zuciya mai tsanani suna cikin lokacin da za a yi amfani da maganin thrombolytic cikin awanni 4.5-6 bayan fara shi.

2. Gyaran thrombectomy da tiyata

2.1 Gyaran thrombectomy na tiyata

A ƙarƙashin jagorancin na'urar cire ƙwayoyin cuta ta dijital (DSA), ana aika na'urar cire ƙwayoyin cuta zuwa wurin da aka yi wa thrombus ta hanyar catheter don cire ƙwayoyin cuta kai tsaye. Wannan hanyar tana da fa'idodin ƙarancin rauni da kuma murmurewa cikin sauri, kuma ta dace da wasu marasa lafiya waɗanda ba za su iya jure wa ƙwayoyin cuta masu rage yawan ƙwayoyin cuta ba ko kuma waɗanda ke da mummunan tasirin thrombolysis na miyagun ƙwayoyi.

2.2 Gyaran thromb na tiyata

A yanke jijiyoyin jini kai tsaye ta hanyar tiyata don cire thrombus. Ana amfani da wannan hanyar gabaɗaya a cikin yanayi na gaggawa inda ba za a iya aiwatar da thrombolysis na magani da kuma thrombus na shiga tsakani ba ko kuma tasirin ba shi da kyau, kamar embolism na jijiyoyin ƙananan ƙafafu. Thrombectomy na tiyata na iya dawo da kwararar jini cikin sauri, amma raunin tiyatar yana da girma kuma akwai ƙarin rikitarwa bayan tiyata.

Ko da wace hanya aka zaɓa, ana buƙatar magani na musamman a ƙarƙashin jagorancin likita bisa ga takamaiman yanayin majiyyaci, kamar wurin da yake, girmansa, lokacin samuwar thrombus, da kuma yanayin lafiyar majiyyaci gaba ɗaya. A lokaci guda, bayan an yi tiyatar thrombolysis ko cirewar thrombus, ana buƙatar maganin hana zubar jini, maganin hana zubar jini da sauran magunguna don hana sake samuwar thrombus.

Kamfanin FASAHA NA BEIJING INC.

GYARAN HADA HADIN AYYUKAN MAI TARIN HADAWA

APPLICATION NA ANALYZER REAGENS

Kamfanin Succeeder Technology Inc.(lambar hannun jari: 688338) ta himmatu sosai a fannin gano cutar coagulation tun lokacin da aka kafa ta a shekarar 2003, kuma ta himmatu wajen zama jagora a wannan fanni. Kamfanin da ke hedikwata a Beijing, yana da ƙungiyar bincike da ci gaba, samarwa da tallace-tallace masu ƙarfi, suna mai da hankali kan ƙirƙira da amfani da fasahar gano cutar thrombosis da hemostasis.

Tare da ƙarfin fasaha mai ban mamaki, Succeeder ya lashe haƙƙin mallaka guda 45 da aka amince da su, waɗanda suka haɗa da haƙƙin mallaka guda 14 na ƙirƙira, haƙƙin mallaka guda 16 na samfuran amfani da haƙƙin mallaka guda 15. Kamfanin yana kuma da takaddun shaidar rajistar samfuran na'urorin likitanci guda 32 na Aji II, takaddun shaida na shigarwa na Aji I guda 3, da kuma takardar shaidar CE ta EU ga samfura 14, kuma ya wuce takardar shaidar tsarin kula da inganci na ISO 13485 don tabbatar da inganci da kwanciyar hankali na ingancin samfura.

Succeeder ba wai kawai wani muhimmin kamfani ne na Shirin Ci Gaban Masana'antar Magungunan Halittu na Beijing (G20) ba, har ma ya samu nasarar shiga Hukumar Kirkire-kirkire ta Kimiyya da Fasaha a shekarar 2020, wanda hakan ya kai ga ci gaban kamfanin. A halin yanzu, kamfanin ya gina hanyar sadarwa ta tallace-tallace a duk fadin kasar da ta shafi daruruwan wakilai da ofisoshi. Ana sayar da kayayyakinsa sosai a mafi yawan sassan kasar. Haka kuma yana fadada kasuwannin kasashen waje tare da ci gaba da inganta gasa a duniya.